Tracheomalacia, Cystic Lung Malformations, Post-Vascular Ring with central airway compression, Lobar Hyperinflation Syndrome, BronchoPulmonary Dysplasia, Bronchiectasis, Chronic Atelectasis
Conditions
Brief summary
Difference in the number of respiratory exacerbations between the treatment groups in the intervention period in the intervention period
Detailed description
Difference in duration of exacerbations between the treatment groups in the intervention period, Difference in number of hospital admissions between the treatment groups in the intervention period, Difference in duration of hospital admissions between the treatment groups in the intervention period
Interventions
DRUGZITHROMAX 40 mg/ml pulver till oral suspension
Sponsors
Rigshospitalet
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in the number of respiratory exacerbations between the treatment groups in the intervention period in the intervention period | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in duration of exacerbations between the treatment groups in the intervention period, Difference in number of hospital admissions between the treatment groups in the intervention period, Difference in duration of hospital admissions between the treatment groups in the intervention period | — |
Countries
Denmark
Outcome results
None listed